Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation.
暂无分享，去创建一个
P. Hari | M. Pasquini | M. Horowitz | B. Shaw | A. Visotcky | A. D’Souza | W. Saber | Mei-Jie Zhang | N. Shah | M. Hamadani | T. Fenske | S. Chhabra | B. Dhakal | W. Drobyski | Xiao-Ying Tang | Lyndsey Runaas | F. Zhu | Robert Thompson | S. Abedin | James H Jerkins | J. Douglas Rizzo | J. Jerkins | L. Runaas